33.44 - 34.57
31.40 - 61.90
7.61M / 5.87M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
15.54%
Revenue growth above 1.5x CFLT's 5.18%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.47%
Gross profit growth above 1.5x CFLT's 8.92%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-9.37%
Negative EBIT growth while CFLT is at 1.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.37%
Negative operating income growth while CFLT is at 1.93%. Joel Greenblatt would press for urgent turnaround measures.
-6.24%
Negative net income growth while CFLT stands at 1.27%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-6.25%
Negative EPS growth while CFLT is at 4.65%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-6.25%
Negative diluted EPS growth while CFLT is at 4.65%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.58%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-11.88%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while CFLT stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-100.00%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
100.00%
Positive BV/share change while CFLT is negative. John Neff sees a clear edge over a competitor losing equity.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
16.60%
R&D growth drastically higher vs. CFLT's 1.72%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
10.50%
SG&A growth well above CFLT's 2.61%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.